Abstract

PurposeTo compare efficacy and safety of once-daily zonisamide (ZNS) and twice-daily controlled-release carbamazepine (CBZ) monotherapy in adults with newly diagnosed partial epilepsy.MethodsPhase III, international, randomised, double-blind, non-inferiority trial, in which...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call